DEBORAH SCHADY to Clinical Trials, Phase I as Topic
This is a "connection" page, showing publications DEBORAH SCHADY has written about Clinical Trials, Phase I as Topic.
Connection Strength
0.060
-
Hyperleukocytosis in a neuroblastoma patient after treatment with natural killer T cells expressing a GD2-specific chimeric antigen receptor and IL-15. J Immunother Cancer. 2025 Jan 11; 13(1).
Score: 0.060